Latest Astute Medical Inc. Stories
Company Joins in Call to Eliminate Preventable Deaths by 2025 SAN DIEGO, March 17, 2015 /PRNewswire/ -- Astute Medical, Inc.
Studies Examine Use of Biomarkers in Patients with Risk Factors for Acute Kidney Injury SAN DIEGO, March 16, 2015 /PRNewswire/ -- Astute Medical, Inc., developer of the NEPHROCHECK(®) Test,
Highlights Educational Forums Focusing on Link Between Acute Kidney Injury Biomarkers and Patient Care SAN DIEGO, Feb.
SAN DIEGO and MARCY L'ETOILE, France, Jan.
SAN DIEGO, Jan. 13, 2015 /PRNewswire/ -- Citing a study recently published online in the Journal of the American Society of Nephrology (JASN), Astute Medical, Inc.
SAN DIEGO, Oct. 9, 2014 /PRNewswire/ -- Astute Medical, Inc.
NephroCheck® Test System Receives FDA Clearance In United States For Risk Assessment Of Acute Kidney Injury SAN DIEGO, Sept.
Collaboration to Expand Sales Breadth and Market Access SAN DIEGO, July 28, 2014 /PRNewswire/ -- Astute Medical, Inc.
Symposium Highlights New Biomarkers for AKI Risk Assessment SAN DIEGO, March 3, 2014 /PRNewswire/ -- Leading critical care experts will discuss biomarkers for risk assessment of
SCCM Event Examines Groundbreaking AKI Risk Assessment Biomarkers SAN DIEGO, Jan.
- A serpent whose bite was fabled to produce intense thirst.